Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Parkes

Showing results (81-90 of 177) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|August 17, 1974
Letter: Propranolol in Parkinson's diseaseC D Marsden, J D Parkes, J E Rees
Psychological Medicine|February 1, 1976
Psychiatric symptoms during l-dopa therapy for Parkinson's disease and their relationship to physical disabilityR H Mindham, C D Marsden, J D Parkes
Lancet (London, England)|February 25, 1999
Analysis of the monoamine oxidase genes and the Norrie disease gene locus in narcolepsyH Koch, I Craig, M Dahlitz, et al.
Postgraduate Medical Journal|February 1, 1971
L-dopa and amantadine hydrochloride in extra-pyramidal disordersJ D Parkes, R P Knill-Jones, P J Clements
British Journal of Clinical Pharmacology|June 1, 1977
Amphetamines, growth hormone and narcolepsyJ D Parkes, A G Debono, P Jenner, et al.
Molecular Endocrinology (Baltimore, Md.)|October 1, 1993
Corticotropin-releasing factor activates c-fos, NGFI-B, and corticotropin-releasing factor gene expression within the paraventricular nucleus of the rat hypothalamusD Parkes, S Rivest, S Lee, et al.
Diabetes, Obesity & Metabolism|November 21, 2012
No evidence of drug-induced pancreatitis in rats treated with exenatide for 13 weeksK Tatarkiewicz, P Belanger, G Gu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1992
The delayed sleep phase syndrome: clinical and investigative findings in 14 subjectsB Alvarez, M J Dahlitz, J Vignau, et al.
Acta Neurologica Scandinavica|November 11, 2009
Natural history, symptoms and treatment of the narcoleptic syndromeJ D Parkes, M Baraitser, C D Marsden, et al.
Clinical Neuropharmacology|January 1, 1984
A double-blind trial of clonazepam in benign essential tremorC Thompson, A Lang, J D Parkes, et al.
Pageof 18

Showing results (81-90 of 177) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|August 17, 1974
Letter: Propranolol in Parkinson's diseaseC D Marsden, J D Parkes, J E Rees
Psychological Medicine|February 1, 1976
Psychiatric symptoms during l-dopa therapy for Parkinson's disease and their relationship to physical disabilityR H Mindham, C D Marsden, J D Parkes
Lancet (London, England)|February 25, 1999
Analysis of the monoamine oxidase genes and the Norrie disease gene locus in narcolepsyH Koch, I Craig, M Dahlitz, et al.
Postgraduate Medical Journal|February 1, 1971
L-dopa and amantadine hydrochloride in extra-pyramidal disordersJ D Parkes, R P Knill-Jones, P J Clements
British Journal of Clinical Pharmacology|June 1, 1977
Amphetamines, growth hormone and narcolepsyJ D Parkes, A G Debono, P Jenner, et al.
Molecular Endocrinology (Baltimore, Md.)|October 1, 1993
Corticotropin-releasing factor activates c-fos, NGFI-B, and corticotropin-releasing factor gene expression within the paraventricular nucleus of the rat hypothalamusD Parkes, S Rivest, S Lee, et al.
Diabetes, Obesity & Metabolism|November 21, 2012
No evidence of drug-induced pancreatitis in rats treated with exenatide for 13 weeksK Tatarkiewicz, P Belanger, G Gu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1992
The delayed sleep phase syndrome: clinical and investigative findings in 14 subjectsB Alvarez, M J Dahlitz, J Vignau, et al.
Acta Neurologica Scandinavica|November 11, 2009
Natural history, symptoms and treatment of the narcoleptic syndromeJ D Parkes, M Baraitser, C D Marsden, et al.
Clinical Neuropharmacology|January 1, 1984
A double-blind trial of clonazepam in benign essential tremorC Thompson, A Lang, J D Parkes, et al.
Pageof 18